• Crystagen 20 mg x 10 Vials

    Crystagen 20 mg: Crystagen is a short-peptide catalogue designation. Analytical evaluation starts by resolving what the catalogue name represents in the supplied material. Sequence-defined short peptides, chemically modified analogues and heterogeneous mixtures require different reference strategies; they should not inherit numerical chemistry simply because their product titles look similar. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Adamax 5 mg x 10 Vials

    Explore Adamax 5 mg in Australia at AU Peptides Shop. Review the listed specifications, available options and product documentation. Contact the team for bulk research enquiries. Research use only; not for human or veterinary use.

  • Vilon 20 mg x 10 Vials

    Vilon 20 mg: Vilon is the synthetic dipeptide Lys-Glu. Analytical evaluation starts by resolving what the catalogue name represents in the supplied material. Sequence-defined short peptides, chemically modified analogues and heterogeneous mixtures require different reference strategies; they should not inherit numerical chemistry simply because their product titles look similar. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • ACE-031 1mg x 10 Vials

    ACE-031 1 mg: ACE-031 is a research designation associated with an activin-receptor-derived fusion protein. A fusion construct is chemically more complex than a short synthetic peptide, and its structural identity includes the receptor-derived domain and fusion architecture. Expression-related modifications can also be relevant. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • B7-33 6mg x 10 Vials

    B7-33 6mg: B7-33 is a single-chain peptide derivative associated with relaxin research and the RXFP1 receptor. Published experimental work distinguishes it from the two-chain architecture of native relaxin. The sequence design is therefore relevant when comparing reference materials and receptor-model results. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Astressin 10 mg x 10 Vials

    Astressin 10 mg: Astressin is a peptide antagonist designation associated with corticotropin-releasing-factor receptor research. The name must be distinguished from related analogues such as Astressin-B and Astressin2-B. Closely named peptides may differ in sequence, cyclisation and receptor-associated experimental properties. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • PNC-27 5 mg x 10 Vials

    PNC-27 5 mg: PNC-27 is a synthetic chimeric peptide discussed in experimental p53-related peptide research. Its identity includes a p53-derived region and a membrane-interacting segment. A short parent-fragment description therefore does not fully identify the complete chimeric molecule. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Cardiogen 20 mg x 10 Vials

    Explore Cardiogen 20 mg in Australia at AU Peptides Shop. Review the listed specifications, available options and product documentation. Contact the team for bulk research enquiries. Research use only; not for human or veterinary use.

  • Ovagen 20 mg x 10 Vials

    Explore Ovagen 20 mg in Australia at AU Peptides Shop. Review the listed specifications, available options and product documentation. Contact the team for bulk research enquiries. Research use only; not for human or veterinary use.

  • Vesugen 20 mg x 10 Vials

    Vesugen 20 mg: Vesugen is a short-peptide catalogue designation. Analytical evaluation starts by resolving what the catalogue name represents in the supplied material. Sequence-defined short peptides, chemically modified analogues and heterogeneous mixtures require different reference strategies; they should not inherit numerical chemistry simply because their product titles look similar. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Humanin 10 mg x 10 Vials

    Humanin 10 mg: Humanin is a peptide associated with mitochondrial-derived peptide research. Published work also discusses modified Humanin analogues, which must be distinguished from the parent sequence. A reference selected for a substituted analogue may not describe a product sold simply as Humanin. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Hexarelin Acetate 5mg x 10 Vials

    Hexarelin Acetate 5mg: Hexarelin is a synthetic hexapeptide associated with growth-hormone-secretagogue receptor research. Its residue substitutions distinguish it from other six-residue peptides in the same broad research family. The acetate wording in a product title identifies an additional supplied-form consideration. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • P-21 10 mg x 10 Vials

    P-21 10 mg: P-21 is a modified short-peptide research designation. Analytical evaluation starts by resolving what the catalogue name represents in the supplied material. Sequence-defined short peptides, chemically modified analogues and heterogeneous mixtures require different reference strategies; they should not inherit numerical chemistry simply because their product titles look similar. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • PE-22-28 10 mg x 10 Vials

    PE-22-28 10 mg: PE-22-28 is a peptide-fragment research designation associated with spadin-related studies. Analytical evaluation starts by resolving what the catalogue name represents in the supplied material. Sequence-defined short peptides, chemically modified analogues and heterogeneous mixtures require different reference strategies; they should not inherit numerical chemistry simply because their product titles look similar. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Bronchogen 20 mg x 10 Vials

    Bronchogen 20 mg: Bronchogen is a synthetic tetrapeptide with the sequence Ala-Asp-Glu-Leu in the cited experimental literature. Published work has examined its interaction with DNA in defined laboratory systems. Its small sequence distinguishes it from longer peptide preparations and tissue-derived mixtures. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Cartalax 20 mg x 10 Vials

    Cartalax 20 mg: Cartalax is a short-peptide catalogue designation associated in the selected PubChem reference with alanyl-glutamyl-aspartic acid. This is a defined three-residue reference species. The sequence and terminal groups in the actual product documents should match that reference before it is used to interpret a supplied sample. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Cerebrolysin 60mg x 10 Vials

    Cerebrolysin 60mg: Cerebrolysin is a complex peptide-containing mixture rather than a single defined synthetic sequence. Analytical evaluation starts by resolving what the catalogue name represents in the supplied material. Sequence-defined short peptides, chemically modified analogues and heterogeneous mixtures require different reference strategies; they should not inherit numerical chemistry simply because their product titles look similar. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

  • Cortagen 20mg x 10 Vials

    Cortagen 20mg: Cortagen is the synthetic tetrapeptide Ala-Glu-Asp-Pro. Analytical evaluation starts by resolving what the catalogue name represents in the supplied material. Sequence-defined short peptides, chemically modified analogues and heterogeneous mixtures require different reference strategies; they should not inherit numerical chemistry simply because their product titles look similar. This listing uses a vial presentation; finished-format specifications must be distinguished from the reference molecule. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.

Main Menu